Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.
about
Antiviral therapies: focus on hepatitis B reverse transcriptaseLong-term outcomes of add-on adefovir dipivoxil therapy to ongoing lamivudine in patients with lamivudine-resistant chronic hepatitis B.Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: a 5-year study of patients with hepatitis B with lamivudine resistance.
P2860
Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Importance of serum concentrat ...... resistant chronic hepatitis B.
@ast
Importance of serum concentrat ...... resistant chronic hepatitis B.
@en
Importance of serum concentrat ...... resistant chronic hepatitis B.
@nl
type
label
Importance of serum concentrat ...... resistant chronic hepatitis B.
@ast
Importance of serum concentrat ...... resistant chronic hepatitis B.
@en
Importance of serum concentrat ...... resistant chronic hepatitis B.
@nl
prefLabel
Importance of serum concentrat ...... resistant chronic hepatitis B.
@ast
Importance of serum concentrat ...... resistant chronic hepatitis B.
@en
Importance of serum concentrat ...... resistant chronic hepatitis B.
@nl
P2093
P2860
P356
P1476
Importance of serum concentrat ...... -resistant chronic hepatitis B
@en
P2093
C Nelson Hayes
Fukiko Mitsui
Harue Igarashi
Hiromi Abe
Hiromi Saneto
Hiroshi Aikata
Kazuaki Chayama
Kentaro Morimoto
Masao Shimizu
Masataka Tsuge
P2860
P304
P356
10.1128/AAC.01372-09
P407
P50
P577
2010-05-24T00:00:00Z